WASHINGTON, D.C. — On Monday, March 17, 2026, the U.S. House of Representatives Select Committee on China launched a formal investigation into several Wall Street underwriters, including Dominari Securities, a firm with direct ties to the Trump family. The congressional probe centers on allegations that these financial intermediaries helped Chinese companies execute stock manipulation schemes on American exchanges, potentially defrauding U.S. investors of billions. This investigation marks a significant escalation in regulatory scrutiny of cross-border financial activities and places a prominent political family at the center of a complex securities fraud case.
Congressional Committee Targets Three Wall Street Underwriters
The House Select Committee on China, chaired by Representative John Moolenaar (R-MI) with Ranking Member Ro Khanna (D-CA), sent detailed letters to three U.S. firms: D. Boral Capital, Dominari Securities, and Revere Securities. These letters, obtained by news outlets, demand comprehensive documentation regarding Chinese initial public offerings (IPOs) the companies helped underwrite. Lawmakers specifically accuse the firms of facilitating “ramp-and-dump” schemes. Consequently, they have given the companies a tight deadline, requiring submission of all requested materials by Friday, March 21st.
Committee staff described the alleged schemes in stark terms. Chinese shell companies, they claim, used U.S. IPOs as a vehicle to artificially inflate share prices. Coordinated trading networks then placed nearly identical buy orders above the IPO price. This activity temporarily boosted valuations before company insiders sold their stakes. Ultimately, retail investors were left holding worthless securities after the orchestrated collapse. The mechanics of these operations suggest sophisticated, cross-jurisdictional coordination.
Billions in Investor Wealth Allegedly Drained Since 2023
The financial impact of these alleged schemes is staggering. Lawmakers cited internal estimates indicating approximately $16 billion in U.S. investor wealth has been lost since 2023 through such manipulation. Furthermore, they pointed to Federal Bureau of Investigation (FBI) data showing a 300% increase in complaints tied to Chinese stock manipulation cases over the same period. This data paints a picture of a rapidly growing threat to market integrity.
- Massive Financial Losses: The $16 billion figure represents a conservative estimate from congressional analysts, who note losses may be higher due to underreporting.
- Exponential Growth in Complaints: The FBI’s reported tripling of cases signals to regulators that existing enforcement mechanisms are being overwhelmed.
- Erosion of Market Confidence: Beyond direct losses, these schemes undermine trust in U.S. capital markets as a safe venue for global investment.
Regulatory Warnings and Prior Scrutiny
The committee’s letters referenced previous public warnings issued by the Financial Industry Regulatory Authority (FINRA). For years, FINRA has alerted member firms about red flags associated with certain Chinese issuers. These include opaque corporate structures, auditing firms not subject to Public Company Accounting Oversight Board (PCAOB) inspection, and convoluted variable interest entity (VIE) arrangements. Despite these warnings, the underwriters proceeded with the IPOs in question. A former SEC enforcement official, speaking on background, noted the challenge. “The due diligence burden on underwriters for foreign issuers is immense,” they said. “When that issuer is from a jurisdiction with limited regulatory cooperation, the risks multiply exponentially.”
Dominari Securities Draws Intense Scrutiny Over Trump Family Ties
Among the firms named, Dominari Securities has attracted the most attention due to its high-profile connections. The brokerage is located in New York’s Trump Tower and is owned by Dominari Holdings. Eric Trump, son of former President Donald Trump, is the company’s fourth-largest shareholder. Both Eric Trump and Donald Trump Jr. joined the firm’s advisory board in February 2025, a move that brought significant media coverage. This corporate history directly links a congressional financial probe to a former First Family.
Dominari’s recent activities extend beyond traditional underwriting. Last year, the firm helped facilitate fundraising for Thumzup, a public company that adopted a Bitcoin treasury strategy. Donald Trump Jr. also invested millions of dollars in Thumzup, creating another layer of financial interconnection. While the Thumzup deal is not part of the current Chinese stock probe, it demonstrates Dominari’s involvement in novel and high-risk financial ventures. The company now faces the difficult task of disentangling its legitimate business from the allegations now under a congressional microscope.
| Underwriter Firm | Key Allegation | Notable Connection |
|---|---|---|
| Dominari Securities | Facilitated IPOs for Chinese firms later involved in ramp-and-dump schemes | Owned by Dominari Holdings; Eric Trump is 4th-largest shareholder; Trump Jr. on advisory board |
| D. Boral Capital | Underwrote multiple Chinese listings that subsequently crashed | Specializes in small-cap and international listings |
| Revere Securities | Acted as placement agent for questionable Chinese offerings | Long history in microcap markets |
Broader Implications for U.S.-China Financial Relations
This investigation does not occur in a vacuum. It unfolds against a backdrop of prolonged tension between U.S. and Chinese regulatory bodies. For over a decade, the PCAOB struggled to gain access to audit working papers for Chinese companies listed in the United States. A landmark 2022 agreement provided a framework for inspections, but implementation remains patchy. The alleged schemes exploit this persistent regulatory gap. If U.S. underwriters are found complicit, either through negligence or willful ignorance, it could trigger a major reevaluation of cross-listings.
Market analysts warn of potential collateral damage. “Legitimate Chinese companies seeking U.S. capital already face a ‘guilt by association’ discount,” said Linette Chen, a senior fellow at the Brookings Institution. “A high-profile scandal involving manipulation and prominent underwriters could further chill the entire ecosystem.” The probe may accelerate legislative efforts, like the proposed Holding Foreign Companies Accountable Act amendments, which would impose stricter delisting timelines for non-compliant firms.
Stakeholder Reactions and Legal Precedents
Reactions from the financial and legal communities have been swift. Shareholder advocacy groups have praised the committee’s action. “Main Street investors are tired of being the exit liquidity for these orchestrated scams,” stated the head of the Investor Protection Trust. Meanwhile, defense attorneys specializing in white-collar cases anticipate a wave of civil litigation. They point to precedent like the SEC v. Shanghai case, where courts established liability for underwriters who disregarded glaring red flags. The firms themselves have been quiet. As of publication, none of the three named underwriters have issued public statements regarding the congressional letters, a silence that legal experts interpret as a sign of serious internal deliberation.
Conclusion
The congressional investigation into Dominari Securities and other underwriters represents a critical test of U.S. market safeguards. It intertwines complex financial fraud allegations with the politically sensitive backdrop of the Trump family’s business dealings. The core facts are clear: lawmakers allege a $16 billion fraud facilitated by Wall Street gatekeepers. The coming weeks will determine whether the firms can provide adequate documentation to satisfy the committee’s concerns or if the probe will expand into a wider examination of industry practices. For investors, the case underscores the enduring risks in cross-border listings. For regulators, it highlights the urgent need for enforceable international cooperation. The outcome will resonate through boardrooms, regulatory agencies, and the halls of Congress, shaping the future of how Chinese companies access American capital.
Frequently Asked Questions
Q1: What is the House Select Committee on China investigating?
The committee is investigating three U.S. underwriters—Dominari Securities, D. Boral Capital, and Revere Securities—over their role in bringing Chinese companies to U.S. stock markets. Lawmakers allege these companies were later involved in “ramp-and-dump” stock manipulation schemes that defrauded American investors.
Q2: How is the Trump family connected to this probe?
Dominari Securities is owned by Dominari Holdings, where Eric Trump is the fourth-largest shareholder. Both Eric Trump and Donald Trump Jr. joined the company’s advisory board in February 2025. The firm’s offices are located in Trump Tower in New York.
Q3: How much money have investors allegedly lost?
Congressional estimates cited in the investigation letters indicate approximately $16 billion in U.S. investor wealth has been drained since 2023 through the alleged Chinese stock manipulation schemes.
Q4: What is a “ramp-and-dump” scheme?
It’s a form of stock manipulation where fraudsters artificially inflate (“ramp”) a stock’s price through coordinated trading and promotional activity, then sell (“dump”) their own shares at the peak before the price collapses, leaving other investors with significant losses.
Q5: What happens next in the congressional investigation?
The three underwriters have been asked to submit requested documents—including communications, trading records, and due diligence policies—by Friday, March 21, 2026. The committee will then review the materials and decide whether to hold public hearings, issue subpoenas, or draft legislative recommendations.
Q6: How does this affect ordinary investors in Chinese stocks?
This probe highlights the specific risks of investing in companies from jurisdictions with differing regulatory standards. Investors are advised to scrutinize an underwriter’s reputation, understand a foreign company’s audit status, and be wary of stocks with unusual trading patterns or promotional hype.
